Guidelines on neonatal screening and painful vaso-occlusive crisis in sickle cell disease: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Project guidelines: Associação Médica Brasileira - 2016.

Revista Brasileira de Hematologia e Hemoterapia

Volumn 38, Issue 2, 2016, Pages 147-157

  Braga, Josefina Aparecida Pellegrini ^a   Veríssimo, Mônica Pinheiro de Almeida ^b   Saad, Sara Teresinha Olalla ^c   Cançado, Rodolfo Delfini ^d,e   Loggetto, Sandra Regina ^f  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b CENTRO INFANTIL BOLDRINI   (Brazil)

^c UNIVERSITY OF CAMPINAS   (Brazil)

^d FACULDADE DE CIÊNCIAS MÉDICAS DA SANTA CASA DE SÃO PAULO   (Brazil)

^e HOSPITAL SAMARITANO   (Brazil)

^f Departamento de Hematologia   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; BENZODIAZEPINE; CARBAMAZEPINE; CHLORPHENIRAMINE; CODEINE; CORTICOSTEROID; DEXAMETHASONE; DIFLUNISAL; DIPYRONE; IBUPROFEN; KETOROLAC; MAGNESIUM; MEPREDNISONE; MORPHINE; NITRIC OXIDE; OPIATE; PARACETAMOL; PETHIDINE; PIRACETAM; TRAMADOL;

AFRICAN AMERICAN OUCHER SCALE; ANALGESIA; ARTICLE; BLOOD TRANSFUSION; BLOOD VESSEL OCCLUSION; BONE SCINTISCANNING; CLINICAL FEATURE; ELECTROPHORESIS; FRACTURE; GENETIC VARIABILITY; HEMOGLOBINOPATHY; HUMAN; HYDRATION; META ANALYSIS (TOPIC); NEWBORN SCREENING; OSTEOMYELITIS; OXYGEN THERAPY; PAIN INTENSITY; PHASE 3 CLINICAL TRIAL (TOPIC); PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SICKLE CELL ANEMIA; VISUAL ANALOG SCALE; WONG BAKER FACES PAIN SCALE;

EID: 84963944158     PISSN: 15168484     EISSN: 18060870     Source Type: Journal    
DOI: 10.1016/j.bjhh.2016.04.001     Document Type: Article

References (81)

1. National Institute of Health, National Heart, Lung, and Blood Institute, Division of Blood Diseases and Resources The management of sickle cell disease 2002.
2. Agência Nacional de Vigilância Sanitária (Anvisa) Manual de Diagnóstico e Tratamento de Doenças Falciformes 2002, 142. Available from: http://bvsms.saude.gov.br/bvs/publicacoes/anvisa/diagnostico.pdf [cited 10.01.15] [Internet].
3. Braga J.A., Loggetto S.R., Campanaro C.M., Lyra I.M., Viana M.B., Anjos A.C., et al. Doença falciforme. Hematologia e Hemoterapia Pediátrica 2014, 139-162. Atheneu, São Paulo. S.R. Loggetto, J.A. Braga, L.G. Tone (Eds.).
4. Shafer F.E., Lorey F., Cunningham G.C., Klumpp C., Vichinsky E., Lubin B. Newborn screening for sickle cell disease: 4 years of experience from California's newborn screening program. J Pediatr Hematol Oncol 1996, 18(1):36-41.
5. Brandelise S., Pinheiro V., Gabetta C.S., Hambleton I., Serjeant B., Serjeant G. Newborn screening for sickle cell disease in Brazil: the Campinas experience. Clin Lab Haematol 2004, 26(1):15-19.
6. Wagner S.C., de Castro S.M., Gonzalez T.P., Santin A.P., Zaleski C.F., Azevedo L.A., et al. Neonatal screening for hemoglobinopathies: results of a public health system in South Brazil. Genet Test Mol Biomarkers 2010, 14(4):565-569.
7. Magalhães P.K., Turcato M.de F., Angulo Ide L., Maciel L.M. Neonatal screening program at the university hospital of the Ribeirão Preto School of Medicine, São Paulo University, Brazil. Cad Saude Publica 2009, 25(2):445-454.
8. Streetly A., Latinovic R., Hall K., Henthorn J. Implementation of universal newborn bloodspot screening for sickle cell disease and other clinically significant haemoglobinopathies in England: screening results for 2005-7. J Clin Pathol 2009, 62(1):26-30.
9. Ducrocq R., Pascaud O., Bévier A., Finet C., Benkerrou M., Elion J. Strategy linking several analytical methods of neonatal screening for sickle cell disease. J Med Screen 2001, 8(1):8-14.
10. Almeida A.M., Henthorn J.S., Davies S.C. Neonatal screening for haemoglobinopathies: the results of a 10-year programme in an English Health Region. Br J Haematol 2001, 112(1):32-35.
11. Lê P.Q., Ferster A., Cotton F., Vertongen F., Vermylen C., Vanderfaeillie A., et al. Sickle cell disease from Africa to Belgium, from neonatal screening to clinical management. Med Trop (Mars) 2010, 70(5-6):467-470.
12. Bardakdjian-Michau J., Bahuau M., Hurtrel D., Godart C., Riou J., Mathis M., et al. Neonatal screening for sickle cell disease in France. J Clin Pathol 2009, 62(1):31-33.
13. Diniz D., Guedes C., Barbosa L., Tauil P.L., Magalhães I. Prevalence of sickle cell trait and sickle cell anemia among newborns in the Federal District, Brazil, 2004 to 2006. Cad Saude Publica 2009, 25(1):188-194.
14. Paixão M.C., Cunha Ferraz M.H., Januário J.N., Viana M.B., Lima J.M. Reliability of isoelectrofocusing for the detection of Hb S Hb C, and HB D in a pioneering population-based program of newborn screening in Brazil. Hemoglobin 2001, 25(3):297-303.
15. Lobo C.L., Bueno L.M., Moura P., Ogeda L.L., Castilho S., de Carvalho S.M. Neonatal screening for hemoglobinopathies in Rio de Janeiro, Brazil. Rev Panam Salud Publica 2003, 13(2-3):154-159.
16. Watanabe A.M., Pianovski M.A., Zanis Neto J., Lichtvan L.C., Chautard-Freire-Maia E.A., Domingos M.T., et al. Prevalence of hemoglobin S in the State of Parana, Brazil, based on neonatal screening. Cad Saude Publica 2008, 24(5):993-1000.
17. Adorno E.V., Couto F.D., Moura Neto J.P., Menezes J.F., Rêgo M., Reis M.G., et al. Hemoglobinopathies in newborns from Salvador, Bahia, Northeast Brazil. Cad Saude Publica 2005, 21(1):292-298.
18. Bandeira F.M., Leal M.C., Souza R.R., Furtado V.C., Gomes Y.M., Marques N.M. Hemoglobin "S" positive newborn detected by cord blood and its characteristics. J Pediatr (Rio J) 1999, 75(3):167-171.
19. de Araújo M.C., Serafim E.S., de Castro W.A., de Medeiros T.M. Prevalence of abnormal hemoglobins in newborns in Natal, Rio Grande do Norte, Brazil. Cad Saude Publica 2004, 20(1):123-128.
20. Thuret I., Sarles J., Merono F., Suzineau E., Collomb J., Lena-Russo D., et al. Neonatal screening for sickle cell disease in France: evaluation of the selective process. J Clin Pathol 2010, 63(6):548-551.
21. Miller F.A., Hayeems R.Z., Bombard Y., Little J., Carroll J.C., Wilson B., et al. Clinical obligations and public health programmes: healthcare provider reasoning about managing the incidental results of newborn screening. J Med Ethics 2009, 35(10):626-634.
22. Kladny B., Gettig E.A., Krishnamurti L. Systematic follow-up and case management of the abnormal newborn screen can improve acceptance of genetic counseling for sickle cell or other hemoglobinopathy trait. Genet Med 2005, 7(2):139-142.
23. Bain B.J. Haemoglobinopathy diagnosis: algorithms, lessons and pitfalls. Blood Rev 2011, 25(5):205-213.
24. Boemer F., Vanbellinghen J.F., Bours V., Schoos R. Screening for sickle cell disease on dried blood: a new approach evaluated on 27,000 Belgian newborns. J Med Screen 2006, 13(3):132-136.
25. Ducrocq R., Bévier A., Leneveu A., Maier-Redelsperger M., Bardakdjian-Michau J., Badens C., et al. Compound heterozygosity Hb S/Hb Hope (beta 136 Gly→Asp): a pitfall in the newborn screening for sickle cell disease. J Med Screen 1998, 5(1):27-30.
26. Shapiro B.S. The management of pain in sickle cell disease. Pediatr Clin North Am 1989, 36(4):1029-1045.
27. Smith W.R., Bauserman R.L., Ballas S.K., McCarthy W.F., Steinberg M.H., Swerdlow P.S., et al. Climatic and geographic temporal patterns of pain in the Multicenter Study of Hydroxyurea. Pain 2009, 146(1-2):91-98.
28. Slovis C.M., Talley J.D., Pitts R.B. Non relationship of climatologic factors and painful sickle cell anemia crisis. J Chronic Dis 1986, 39(2):121-126.
29. Jones S., Duncan E.R., Thomas N., Walters J., Dick M.C., Height S.E., et al. Windy weather and low humidity are associated with an increased number of hospital admissions for acute pain and sickle cell disease in an urban environment with a maritime temperate climate. Br J Haematol 2005, 131(4):530-533.
30. Nolan V.G., Zhang Y., Lash T., Sebastiani P., Steinberg M.H. Association between wind speed and the occurrence of sickle cell acute painful episodes: results of a case-crossover study. Br J Haematol 2008, 143(3):433-438.
31. West D.C., Romano P.S., Azari R., Rudominer A., Holman M., Sandhu S. Impact of environmental tobacco smoke on children with sickle cell disease. Arch Pediatr Adolesc Med 2003, 157(12):1197-1201.
32. Glassberg J., Spivey J.F., Strunk R., Boslaugh S., DeBaun M.R. Painful episodes in children with sickle cell disease and asthma are temporally associated with respiratory symptoms. J Pediatr Hematol Oncol 2006, 28(8):481-485.
33. Hargrave D.R., Wade A., Evans J.P., Hewes D.K., Kirkham F.J. Nocturnal oxygen saturation and painful sickle cell crises in children. Blood 2003, 101(3):846-848.
34. Nebor D., Bowers A., Hardy-Dessources M.D., Knight-Madden J.M., Romana M., Reid H., et al. Frequency of painful crises in sickle cell anemia and its relationships with the sympatho-vagal balance, blood viscosity and inflammation. Haematologica 2011, 96(11):1589-1594.
35. Yoong W.C., Tuck S.M. Menstrual pattern in women with sickle cell anaemia and its association with sickling crises. J Obstet Gynaecol 2002, 22(4):399-401.
36. Zempsky W.T. Evaluation and treatment of sickle cell pain in the emergency department: paths to a better future. Clin Pediatr Emerg Med 2010, 11(4):265-273.
37. Luffy R., Grove S.K. Examining the validity, reliability, and preference of three pediatric pain measurement tools in African-American children. Pediatr Nurs 2003, 29(1):54-59.
38. Zempsky W.T., Corsi J.M., McKay K. Pain scores: are they used in sickle cell pain?. Pediatr Emerg Care 2011, 27(1):27-28.
39. Frei-Jones M.J., Baxter A.L., Rogers Z.R., Buchanan G.R. Vaso-occlusive episodes in older children with sickle cell disease: emergency department management and pain assessment. J Pediatr 2008, 152(2):281-285.
40. Smith W.R., Penberthy L.T., Bovbjerg V.E., McClish D.K., Roberts J.D., Dahman B., et al. Daily assessment of pain in adults with sickle cell disease. Ann Intern Med 2008, 148:94-101.
41. Jacob E., Miaskowski C., Savedra M., Beyer J.E., Treadwell M., Styles L. Quantification of analgesic use in children with sickle cell disease. Clin J Pain 2007, 23(1):8-14.
42. Lopez B.L., Flenders P., Davis-Moon L., Corbin T., Ballas S.K. Clinically significant differences in the visual analog pain scale in acute vasoocclusive sickle cell crisis. Hemoglobin 2007, 31(4):427-432.
43. Doyle Portugal R., Morgado Loureiro M. Evaluation of pain scale to predict hospital admission in patients with sickle cell disease. Haematologica 2003, 88(4):ELT11.
44. Sporrer K.A., Jackson S.M., Agner S., Laver J., Abboud M.R. Pain in children and adolescents with sickle cell anemia: a prospective study utilizing self-reporting. Am J Pediatr Hematol Oncol 1994, 16(3):219-224.
45. Dunlop R.J., Bennett K.C. Pain management for sickle cell disease. Cochrane Database Syst Rev 2006, (2):CD003350.
46. Kavanagh P.L., Sprinz P.G., Vinci S.R., Bauchnr H., Wang C.J. Management of children with sickle cell disease: a comprehensive review of the literature. Pediatrics 2011, 128(6):e1552-e1574.
47. Okomo U., Meremikwu M.M. Fluid replacement therapy for acute episodes of pain in people with sickle cell disease. Cochrane Database Syst Rev 2012, 6:CD005406.
48. Lottenberg R., Hassell K.L. An evidence-based approach to the treatment of adults with sickle cell disease. Hematol Am Soc Hematol Educ Program 2005, 58-65.
49. U.S.Department of Health and Human Services, Public Health Service, National Institutes of Health, National Heart, Lung, and Blood Institute The management of sickle cell disease. NIH Publication No. 02-2117 2002, Available from: https://www.nhlbi.nih.gov/files/docs/guidelines/sc_mngt.pdf [cited 10.01.15] [Internet].
50. Brunetta D.M., Clé D.V., Haes T.M., Roriz-Filho J.S., Moriguti J.C. Manejo das complicações agudas da doença falciforme. Medicina (Ribeirão Preto) 2010, 43(3):231-237.
51. Ministério da Saúde, Instituto Nacional de Câncer Cuidados paliativos oncológicos: controle da dor 2001, 124. Rio de Janeiro, INCA.
52. World Health Organization Cancer pain relief and palliative care. World Health Organization Techinical Report Series 804 1990, 1-75. World Health Organization, Geneva, Switzerland.
53. WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses 2012, 36-53. World Health Organization, ISBN 978 92 4 154812 0.
54. SCAC (the Sickle Cell Advisory Committee) of GENES (The Genetic Network of New York, Puerto Rico and the Virgin Islands) Guidelines for the treatment of people with sickle cell disease March 2002.
55. Ministério da Saúde, Secretaria de Atençãoà Saúde, Departamento de Atenção Especializada Manual de eventos agudos em doença 2009, Editora do Ministério da Saúde, Brasília, 50 p.: il. [Série A. Normas e Manuais Técnicos].
56. van Beers E.J., van Tuijn C.F., Nieuwkerk P.T., Friederich P.W., Vranken J.H., Biemond B.J. Patient controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial. Am J Hematol 2007, 82(11):955-960.
57. Jacobson S.J., Kopecky E.A., Joshi P., Babul N. Randomised trial of oral morphine for painful episodes of sickle-cell disease in children. Lancet 1997, 350(9088):1358-1361.
58. Griffin T.C., McIntire D., Buchanan G.R. High-dose intravenous methylprednisolone therapy for pain in children and adolescents with sickle cell disease. N Engl J Med 1994, 330(11):733-737.
59. Caboot J.B., Allen J.L. Pulmonary complications of sickle cell disease in children. Curr Opin Pediatr 2008, 20(3):279-287.
60. Gladwin M.T., Kato G.J., Weiner D., Onyekwere O.C., Dampier C., Hsu L., et al. Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trial. JAMA 2011, 305(9):893-902.
61. Ministério da Saúde, Secretaria de Atenção à Saúde, Departamento de Atenção Especializada Manual de condutas básicas na doença falciforme 2006, 56. Editora do Ministério da Saúde, Brasília, [Série A. Normas e Manuais Técnicos].
62. National Institute for Health and Clinical Excellence (NICE) Clinical Guideline 143. Sickle cell acute painful episode: management of an acute painful sickle cell episode in hospital 2012, Available from: https://www.nice.org.uk/guidance/cg143/resources/sickle-cell-disease-managing-acute-painful-episodes-in-hospital-35109569155525 [cited 10.01.15] [Internet].
63. Bartolucci P., El Murr T., Roudot-Thoraval F., Habibi A., Santin A., Renaud B., et al. A randomized, controlled clinical trial of ketoprofen for sickle-cell disease vaso-occlusive crises in adults. Blood 2009, 114(18):3742-3747.
64. Alvim R.C., Viana M.B., Pires M.A., Franklin H.M., Paula M.J., Brito A.C., et al. Inefficacy of piracetam in the prevention of painful crises in children and adolescents with sickle cell disease. Acta Haematol 2005, 113(4):228-233.
65. Al Hajeri A.A., Fedorowicz Z., Omran A., Tadmouri G.O. Piracetam for reducing the incidence of painful sickle cell disease crises. Cochrane Database Syst Rev 2007, (2):CD006111.
66. Goldman R.D., Mounstephen W., Kirby-Allen M., Friedman J.N. Intravenous magnesium sulfate for vaso-occlusive episodes in sickle cell disease. Pediatrics 2013, 132(6):e 1634-e1641.
67. Zipursky A., Robieux I.C., Brown E.J., Shaw D., O'Brodovich H., Kellner J.D., et al. Oxygen therapy in sickle cell disease. Am J Pediatr Hematol Oncol 1992, 14(3):222-228.
68. Robieux I.C., Kellner J.D., Coppes M.J., Shaw D., Brown E., Good C., et al. Analgesia in children with sickle cell crisis: comparison of intermittent opioids vs. continuous intravenous infusion of morphine and placebo-controlled study of oxygen inhalation. Pediatr Hematol Oncol 1992, 9(4):317-326.
69. Sickle Cell Society, Department of Health, UK Forum on Haemoglobin Disorders Standards for the clinical care of adults with sickle cell disease in the UK 2008.
70. Tostes M.A., Braga J.A., Len C.A. Abordagem da crise dolorosa em crianças portadoras de doença falciforme. Rev Ciênc Méd Campinas 2009, 18(1):47-55.
71. Keeley K., Buchanan G.R. Acute infarction of long bones in children with sickle cell anemia. J Pediatr 1982, 101(2):170-175.
72. Amundsen T.R., Siegel M.J., Siegel B.A. Osteomyelitis and infarction in sickle cell hemoglobinopathies: differentiation by combined technetium and gallium scintigraphy. Radiology 1984, 153(3):807-812.
73. Skaggs D.L., Kim S.K., Greene N.W., Harris D., Miller J.H. Differentiation between bone infarction and acute osteomyelitis in children with sickle-cell disease with use of sequential radionuclide bone-marrow and bone scans. J Bone Joint Surg Am 2001, 83A(12):1810-1813.
74. Rao S., Solomon N., Miller S., Dunn E. Scintigraphic differentiation of bone infarction from osteomyelitis in children with sickle cell disease. J Pediatr 1985, 107(5):685-688.
75. Kim H.C., Alavi A., Russell M.O., Schwartz E. Differentiation of bone and bone marrow infarcts from osteomyelitis in sickle cell disorders. Clin Nucl Med 1989, 14(4):249-254.
76. Kahn C.E., Ryan J.W., Hatfield M.K., Martin W.B. Combined bone marrow and gallium imaging. Differentiation of osteomyelitis and infarction in sickle hemoglobinopathy. Clin Nucl Med 1988, 13(6):443-449.
77. Sadat-Ali M., al-Umran K., al-Habdan I., al-Mulhim F. Ultrasonography: can it differentiate between vasoocclusive crisis and acute osteomyelitis in sickle cell disease?. J Pediatr Orthop 1998, 18(4):552-554.
78. William R.R., Hussein S.S., Jeans W.D., Wali Y.A., Lamki Z.A. A prospective study of soft-tissue ultrasonography in sickle cell disease patients with suspected osteomyelitis. Clin Radiol 2000, 55(4):307-310.
79. Inusa B.P., Oyewo A., Brokke F., Santhikumaran G., Jogeesvaran K.H. Dilemma in differentiating between acute osteomyelitis and bone infarction in children with sickle cell disease: the role of ultrasound. PLOS ONE 2013, 8(6):e65001.
80. Lonergan G.J., Cline D.B., Abbondanzo S.L. Sickle cell anemia. Radiographics 2001, 21(4):971-994.
81. Berger E., Saunders N., Wang L., Friedman J.N. Sickle cell disease in children: differentiating osteomyelitis from vaso-occlusive crisis. Arch Pediatr Adolesc Med 2009, 163(3):251-255.